Company intelligence / Profile preview
Haleon
- Ownership
- Public · HLN
- Employees
- ~24000
- Development stage
- Other
Overview
Haleon operates a global portfolio of leading consumer healthcare brands with commercialized products in over-the-counter medicines, oral health, vitamins/minerals/supplements. The company invests in R&D to support product innovation and claims but does not conduct traditional pharmaceutical clinical trials. Its brands are supported by scientific evidence generation and expert engagement.
- Therapeutic areas
- OtherGastroenterologyInfectious DiseasesRheumatology
- Modalities
- Small molecules (OTC drugs)Nutritional supplements/vitamins/mineralsTopical formulations (creams/gels)Oral care products (toothpastes/mouthwashes)Medical devices for consumer use (e.g., thermometers)
- Industry
- Biotech
Drug pipeline
32 assets31 more assets in the full pipeline.
Partnerships
Financials
- Market cap
- $40.2B
- Total revenue
- $14.8B
- Enterprise value
- $50.1B
Beyond the preview
Go deeper on Haleon.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Haleon.